Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase 1 2Phase EARLY_PHASE1 1Phase 4 1Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 2Pancreatic Neoplasms 1Pain 1Neoplasms 1Nausea 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Dronabinol × Clear all
NCT03984214 2025-04-10

Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer

Arbeitsgemeinschaft medikamentoese Tumortherapie

Phase 3 Completed
109 enrolled
Gastrointestinal

Pancreatic Neoplasms, Vomiting

NCT00674609 2023-05-03

SPRAY

Jazz Pharmaceuticals

Phase 3 Completed
177 enrolled 21 charts

Neoplasms, Pain

NCT00553059 2020-10-09

Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer

M.D. Anderson Cancer Center

Phase 3 Completed
62 enrolled 15 charts

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡